; (C) the Select Committee on Intelligence of the Senate; (D) the Committee on Foreign Relations of the Senate; (E) the Committee on Financial Services of the House of Representatives; (F) the Committee on Agriculture of the House of Representatives; (G) the Permanent Select Committee on Intelligence of the House of Representatives; (H) the Committee on Foreign Affairs of the House of Representatives; (I) the majority leader of the Senate; (J) the minority leader of the Senate; (K) the Speaker of the House of Representatives; and (L) the minority leader of the House of Representatives. (3) Classification The report under paragraph (1) shall be submitted in an unclassified form, but may include a classified annex. (c) Government accountability office report Not later than 1 year after the date of enactment of this Act, the Comptroller General of the United States shall submit to Congress a report describing— (1) a review of resources, staffing, and expertise for carrying out the Agricultural Foreign Investment Disclosure Act of 1978 ( 7 U.S.C. 3501 et seq. ), and enforcement issues limiting the effectiveness of that Act; and (2) any recommended necessary changes to that Act. III Matters relating to medical and national security supply chains 301. Report and recommendation on barriers to domestic manufacturing of medical products (a) Report to congress Not later than 180 days after the date of the enactment of this Act, the Secretary of Health and Human Services (in this section referred to as the Secretary ), acting through the Commissioner of Food and Drugs, shall submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices that are— (1) imported from outside of the United States